Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06427200 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Lactoferrin in Heart Failure Patients

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Interventions: Lactoferrin (Drug), oral Iron (Drug), oral iron plus lactoferrin (Drug) to Lactoferrin (Drug), lactoferrin and oral iron (Drug), oral Iron (Drug)v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cairo University
1,562 trials monitored
See 18 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
This study will be conducted to determine the efficacy and safety of lactoferrin versus oral iron versus lactoferrin plus oral iron as an add on therapy in reduced ejection fraction heart failure patients with iron deficiency. •Patients will be randomly distributed into the three groups * All patients will be subjected to baseline data assessment * Follow up after 12 weeks
Trial Details
NCT Number NCT06427200
Lead Sponsor Cairo University
Conditions
(from sponsor)		 Heart Failure With Reduced Ejection Fraction
Related terms Heart Failure, Iron Deficiencies
Enrollment 114 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov